MétaCan
Menu
Retour à la cohorte
Enregistrement W2054496321 · doi:10.1046/j.1468-3083.2000.00134.x

Quality of life of psoriasis patients

2000· letter· en· W2054496321 sur OpenAlexaff
Madhulika A. Gupta, Aditya K. Gupta

Notice bibliographique

RevueJournal of the European Academy of Dermatology and Venereology · 2000
Typeletter
Langueen
DomaineImmunology and Microbiology
ThématiquePsoriasis: Treatment and Pathogenesis
Établissements canadiensWestern University
Organismes subventionnairesnon disponible
Mots-clésPsoriasisMedicineQuality of life (healthcare)Context (archaeology)DiseaseGerontologySocializationDermatologyPsychologyDevelopmental psychologyNursing

Résumé

récupéré en direct d'OpenAlex

The contribution of the quality of life (QOL) dimension in the overall morbidity caused by psoriasis is being recognized increasingly in mainstream dermatology. This is exemplified by a recent position paper, which proposes that a QOL standard is better than a body surface area measurement for delineating psoriasis severity.1 Furthermore psoriasis has been shown to impact the QOL of the patient to the same degree as other more life-threatening disorders such as diabetes, heart disease and cancer.2 There is a debate about what constitutes QOL, and the definition of QOL ranges from a consideration of the function-based biomedical aspects of the disease with a focus on the patients’ capacity to function in manner that is consistent with their age and social role, to a more individualistic approach which takes into consideration each patients unique ‘life plan’ into consideration. The literature on the QOL assessment in psoriasis has largely focused on the more function-based or health-related QOL approach. The health-related QOL approach considers the impact of psoriasis on the patients’ physical, social, psychological and vocational functioning. The QOL in psoriasis should be assessed within a developmental context. In general, patients in the 18–45 age group experience more frequent problems related to both appearance/socialization and occupation/finances.3 The adverse effect upon the QOL lessens in the over-45 age group, with a further decline in the over-65 age group.3 This most likely reflects the fact that in earlier adulthood, when the individual is first establishing social relationships, entering the workforce and starting their career, the social stigma associated with psoriasis has the greatest impact. Contrary to studies in the 1970s which reported that women were more affected by the cosmetic disfigurement caused by psoriasis, it is important to recognize that in more recent studies both men and women are equally affected by the impact of psoriasis on the appearance and socialization.3 This may in part be indicative of the fact that it is more socially acceptable for men to express concerns about their appearance and in part the fact that an attractive appearance has played an increasingly important role on socialization for men over the last 20 years.3 Another developmental consideration is the finding that younger patients with early onset psoriasis (onset age <40 years) are more likely to have greater genetic susceptibility and tend to experience more severe and recurrent disease.4 Patients with early onset psoriasis are also likely to have certain personality traits, such as greater difficulties with the expression and assertion of anger.5 Most of the psoriasis-related stress arises from the social stigma and resultant reactions of people in social situations, and difficulties with assertiveness may render these patients more vulnerable to the psoriasis-related stresses.5 The clinician should be especially sensitive to this possibly more vulnerable subgroup of patients with early onset psoriasis, who are less likely to readily express or volunteer their feelings. There is a relatively large body of literature on the role of stressful life events in the onset and/or exacerbation of psoriasis. It is important to recognize that the impact of psoriasis upon the QOL can also result in significant daily stress6,7 and greater psychological morbidity8 for the patient. Comparison of the psychocutaneous characteristics of patients who reported that stress exacerbated their psoriasis (i.e. the high stress reactors or HSR) to the subgroup that reported no significant association between stress and their psoriasis (i.e. the low stress reactors or LSR) revealed that the HSR had more cosmetically disfiguring psoriasis in ‘emotionally charged’ areas, i.e. their psoriasis was more severe in body regions such as the face, neck, scalp, forearms, hands and genital region,6 in contrast to the LSR. Among the HSR, psoriasis in these regions is more likely to be cosmetically disfiguring and affect socialization and sexual functioning. As expected, the HSR reported greater psoriasis-related stress than the LSR.6 The HSR also reported more frequent flare-ups of their psoriasis.6 It is possible that in some cases, the chronic low-grade stress or daily hassles resulting from having to cope with the impact of psoriasis upon the QOL can in turn exacerbate the psoriasis. These findings suggest that even clinically mild disease, when cosmetically disfiguring or affecting the genital regions, should be treated aggressively. This may be especially relevant for psoriasis, as in contrast to other stress-reactive dermatoses such as urticaria, acne, alopecia and eczema, psychosocial stressors predated the onset and/or exacerbation of psoriasis most frequently,9 suggesting that psoriasis tends to be the most sensitive to stress. It is important to recognize the presence of depressive disease in psoriasis, which may be primary or secondary to the psoriasis. In a survey of 217 patients, 9.7% of patients reported wishes to be dead and 5.5% reported active suicidal ideation at the time of the study.10 Suicidal ideation in psoriasis was associated with higher depression scores and higher patient self-ratings of psoriasis severity.10 Furthermore, the severity of depression has been shown to increase with increasing pruritus severity, and a decrease in pruritus pre- to post-treatment correlated with a decrease in the severity of depression.11 The depressed clinical state may decrease the threshold for pruritus, which is one of the most distressing symptoms of psoriasis.11 These findings highlight the multifaceted and possibly bidirectional relation between psoriasis severity, psychological factors and QOL, and emphasize the importance of considering the QOL dimension in the overall management of the psoriasis patient. In this issue (pp. 267–271), Devrimci-Ozguven, Kundakci, Kumbasar and Boyvat have examined the effect of stressful life events and psychopathology such as depression and anxiety, on the onset and exacerbation of psoriasis. The authors report that 68% of their 50 subjects reported a stressful life event in the previous 3 months, prior to the onset of their psoriasis, and furthermore there was a direct correlation between psoriasis severity and both ‘low affective expression’ and high depression scores. Their findings are consistent with previous studies and further highlight the importance of the psychosocial dimension in psoriasis.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesIntégrité de la recherche
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,059
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0020,001
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,001
Communication savante0,0000,000
Science ouverte0,0010,000
Intégrité de la recherche0,0010,002
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,028
Tête enseignante GPT0,257
Écart entre enseignants0,229 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeSans objet
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations47
Publié2000
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueJournal of the European Academy of Dermatology and VenereologyMême sujetPsoriasis: Treatment and PathogenesisTravaux en français237 207